Latigo Biotherapeutics Files for Nasdaq IPO, Aims to Bring Sodium-Channel Pain Drug to Market
Latigo Biotherapeutics Inc. announced on July 17 2026 that it has filed a registration statement with the U.S. Securitie...
Read story →
Latigo Biotherapeutics Inc. announced on July 17 2026 that it has filed a registration statement with the U.S. Securitie...
Read story →
Shares of Trump Media & Technology Group Corp. (NASDAQ:DJT) surged 13.1 percent week‑on‑week after the company annou...
Read story →
Glucotrack’s recent takeover of Lōkahi Therapeutics has sent the stock soaring, but the real story lies in how the tw...
Read story →
SpaceX’s first public listing on Nasdaq lit up Wall Street, with shares leaping 19 percent on the day they opened, pro...
Read story →
On June 9, 2026, the Swedish startup Einride AB turned its ambitious vision into a public listing, debuting on Nasdaq un...
Read story →
InstallatørGruppen A/S, a Danish provider of multidisciplinary technical installation services, completed its initial p...
Read story →
On Wednesday, Big Tree Cloud Holdings Ltd’s shares leapt 291.3 % during the main trading session, closing at $7.20. Th...
Read story →
On June 8, 2026, Snow Rothschild Acquisition Corp. (NASDAQ: ISNRU) announced the pricing of its initial public offering ...
Read story →
Fort Technology Inc. (Nasdaq: FRTT, TSXV:FORT) opened its first U.S. trading session at the market’s open on Monday, J...
Read story →
A new wave of AI IPOs could inject nearly $4 trillion in market cap to U.S. exchanges, Bloomberg data shows. SpaceX's fi...
Read story →